Anti-TAT 113 antibodies
AssigneeGenentech, Inc.
InventorsPatrick Dowd, Gretchen Frantz, Paul Polakis, Victoria Smith, Susan D. Spencer, Thomas D. Wu, Zemin Zhang
Life of this patent
Estimating the term…
Abstract
The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
Claims16
An isolated monoclonal antibody that binds to the epitope bound by an antibody produced by any of the hybridoma cell lines selected from the group consisting of 12E5.1.1 (ATCC Accession No. PTA-6625) and 6G10.11 (ATCC Accession No. PTA-6623).
A monoclonal antibody produced by any of the hybridoma cells selected from the group consisting of 12E5.1.1 (ATCC Accession No. PTA-6625) and 6G10.11 (ATCC Accession No. PTA-6623).
A hybridoma cell which produces a monoclonal antibody that binds to the polypeptide of SEQ ID NO:2 wherein the hybridoma cell is selected from the group consisting of 12E5.1.1 (ATCC Accession No. PTA-6625) and 6G10.11 (ATCC Accession No. PTA-6623).
Dependencies are inferred from the claim text.